Affordable Access

deepdyve-link
Publisher Website

Serological Tests for COVID-19: Potential Opportunities.

Authors
  • Tantuoyir, Marcarious M1, 2, 3
  • Rezaei, Nima1, 4, 5
  • 1 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. , (Iran)
  • 2 Biomedical Engineering Unit, University of Ghana Medical Center (UGMC), Accra, Ghana. , (Ghana)
  • 3 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Accra, Ghana. , (Ghana)
  • 4 Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. , (Iran)
  • 5 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. , (Iran)
Type
Published Article
Journal
Cell Biology International
Publisher
Wiley (John Wiley & Sons)
Publication Date
Dec 02, 2020
Identifiers
DOI: 10.1002/cbin.11516
PMID: 33289157
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific IgM and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Report this publication

Statistics

Seen <100 times